4-Fluoropyrazolo[1,5-a]pyridine-3-carboxylic acid, 95.0%, 5g

L-Serine, min. 98.5%, Ph.Eur., 500 g, plastic packaging.

(3S)-1-(Pyridin-2-yl)pyrrolidin-3-amine, 1g

9-Oxo-6,7,8,9-tetrahydro-5h-benzo[7]annulene-2-carboxylic acid, 95+%, 250mg

Direct displacement pipette MICROMAN® E, 10 to 100 µl, 1 piece

2-Chloroethyl isocyanate, 97.0%, 5g

3-(Piperidin-1-yl)propan-1-ol, 95.0%, 5g

(3-Fluorobenzyl)boronic acid pinacol ester, 95.0%, 1g

2(1H)-Pyridinone, 3-[(2S,4S,5R)-5,6-dichloro-2,4-dimethyl-1-oxohexyl]-4-hydroxy-5,6-dimethoxy-, 95%, 10mg

TERT-BUTYL 4-(TRIFLUOROMETHYL)-5,6-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE, 95%, 100mg

6-CHLORO-7-(2-FLUOROBENZYL)-7H-PURINE, 90.0%, 100mg

6-Chloro-3-fluoro-N-(5-methylpyrazin-2-yl)picolinamide, 97%, 250mg

tert-Butyl N-(2-aminoethyl)carbamate, 98.0%, 500g